Healthcare & Assistive
From da Vinci surgical systems to rehab exoskeletons and elder-care companions, robotics is reshaping healthcare. This section grades what works in the clinic vs the marketing.
Topics in Healthcare & Assistive
24 articles
A grounded assessment of the current surgical robotics landscape, grading systems by verified shipping hardware and pilot deployments rather than announcements. Coverage includes da Vinci, Hugo, and Versius, with technical specifications, clinical realities, and India availability with landed cost estimates.
A grounded review of shipping rehab exoskeletons, clinical trial outcomes, regulatory clearances, and the practical realities of deployment and pricing in India.
A factual assessment of commercially available elder-care robots, including ElliQ, Paro, and Lovot, graded by deployment status, technical specifications, and India market availability.
A factual assessment of hospital autonomous mobile robots (AMRs), focusing on Aethon’s TUG delivery fleet and Diligent Robotics’ Moxi companion unit. We grade both systems by verified shipping hardware and pilot deployments, separate manufacturer claims from field performance, and outline India market availability with approximate landed cost estimates.
A hardware-first assessment of commercial rehab exoskeletons, evaluating ReWalk, Ekso Bionics, and Cyberdyne HAL against published clinical evidence, deployment constraints, and India availability with landed cost estimates.
A grounded assessment of shipping elder-care and assistive home companion robots, grading claims by hardware maturity, detailing real-world deployments, technical constraints, and India availability with landed cost estimates.
An objective assessment of autonomous mobile robots for hospital logistics, focusing on Aethon TUG and Moxi. Evaluates claims by shipping hardware first, then pilots, then announcements. Covers technical specifications, integration requirements, safety standards, India availability, and approximate landed costs.
A factual evaluation of the commercial surgical robotics market, graded by shipping hardware, pilot deployments, and regulatory status. Covers Intuitive’s da Vinci, Medtronic’s Hugo RAS, and CMR Surgical’s Versius, with clinical evidence, procurement considerations, and India market availability.
A hardware-first evaluation of the da Vinci, Hugo, and Versius surgical robot platforms, graded by shipping status, clinical integration, and landed cost realities in the Indian healthcare ecosystem.
A grounded assessment of the rehabilitation exoskeleton sector, evaluating ReWalk, Ekso Bionics, and Cyberdyne HAL against manufacturing maturity, clinical evidence, and import viability in India.
A grounded assessment of ElliQ, Paro, Lovot, and assistive home companions. Grading claims by shipping hardware first, pilot deployments second, and announcements last, with explicit notes on India availability, landed costs, and regulatory pathways.
An evidence-based overview of hospital autonomous mobile robots, focusing on shipping hardware, verified deployments, and practical integration of the Aethon TUG and Diligent Robotics Moxi in clinical logistics.
An analysis of the surgical robotics landscape focusing on shipped hardware and clinical deployments, with specific attention to the Indian market's readiness and pricing for soft-tissue procedures.
An evidence-based analysis of commercially available rehabilitation exoskeletons including ReWalk, Ekso, and Cyberdyne HAL. This report grades claims by shipping hardware status, reviews independent clinical data, and provides landed cost estimates for the Indian medical device market.
A critical analysis of shipping elder-care robotics including ElliQ, Paro, and Lovot. We assess hardware readiness, pilot deployments, and realistic pricing for the Indian market without the hype.
An evidence-based review of Aethon TUG and Fetch Robotics’ Moxi in hospital logistics, assessing shipping status, deployment scale, and India market entry.
A grounded assessment of the surgical robotics market, focusing on installed hardware, regulatory clearances, and Indian adoption barriers rather than concept renders. We grade the da Vinci, Hugo RAS, and Versius systems by shipping status, pilot deployments, and regulatory milestones.
An analysis of ReWalk, Ekso, and Cyberdyne HAL focusing on shipped units, clinical data, and India market entry. We grade claims by shipping hardware first, pilot deployments second, and announcements last, with specific reference to Indian availability and regulatory hurdles.
A grounded assessment of ElliQ, Paro, and Lovot in the context of India's aging demographic, focusing on available shipping hardware, pilot deployments, and realistic pricing compared to marketing claims.
An evidence-based review of autonomous mobile robots in hospital settings, focusing on Aethon TUG and Moxi, with specific attention to deployment status and Indian market readiness.
An objective assessment of the current hardware landscape in soft-tissue surgical robotics, focusing on FDA-cleared systems, pilot deployments, and their specific availability and landed cost estimates within the Indian healthcare market.
An analysis of shipping hardware from ReWalk, Ekso, and Cyberdyne HAL, evaluating clinical evidence for neurological recovery and assessing availability and landed costs within the Indian healthcare market.
An evidence-based analysis of shipping elder-care robotics, focusing on ElliQ, Paro, and Lovot. This article evaluates clinical claims, hardware availability, and the specific challenges of importing assistive technology into the Indian market, distinguishing between therapeutic devices and consumer electronics.
An evidence-based review of autonomous mobile robots in healthcare environments, focusing on Aethon TUG and Moxi deployment data, operational safety, and market entry into India. This article grades claims by shipping hardware status, pilot deployments, and manufacturer specifications rather than concept videos.